Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Ovarian Neoplasms 16Lung Neoplasms 15Breast Neoplasms 14Endometrial Neoplasms 13Parkinson Disease 4, Autosomal Dominant Lewy Body 12Fallopian Tube Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 5Esophageal Neoplasms 5Adenocarcinoma Of Esophagus 5Stomach Neoplasms 4Neoplasms 4Melanoma 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Peritoneal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Solid Tumour 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Adenocarcinoma 2Uterine Neoplasms 1

Interventions

Specimen Handling 7Magnetic Resonance Spectroscopy 7Platinum 4Cisplatin 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Intensity-Modulated 3Cetuximab 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2cemiplimab 2Radiotherapy 2Radiation 2Immunoglobulin G 2Disulfides 2Carboplatin 2ipatasertib 1durvalumab 1cabozantinib 1atezolizumab 1Transurethral Resection of Bladder 1Taxes 1Radiosurgery 1Paclitaxel 1Nivolumab 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Paclitaxel × 30 days × Clear all
NCT07195734 2026-05-19

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
180 enrolled
Head & Neck

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡